Gionco David

Avg. Two Year Performance

No purchase track record
22% Avg. Sale Return
11% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return3%(< 1%)3%(4%)22%
Sale Success Rate9 of 155 of 158 of 156 of 157 of 15
Drugs » Biotechnology

Chief Accounting Officer:

Holdings: 35.76K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Chief Accounting Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--